Noonan Syndrome
📧 Sign up to get email alerts when something new happens for Noonan Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Study of Metabolic Modifications in Children With Noonan Syndrome [NA]
A completed clinical trial investigating metabolic modifications in children with Noonan syndrome.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9 [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of somapacitan for pediatric growth disorders; results have been posted for condit…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: Lymphatic Phenotype in Noonan Syndrome Spectrum Disorders [NA]
A completed clinical trial studying lymphatic phenotypes in Noonan syndrome spectrum disorders.
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658 [Phase 3]
A Phase 3 clinical trial update evaluating genetic testing in Noonan syndrome patients who were previously treated with Norditropin, as an e…
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome [Phase 3]
Phase 3 clinical trial evaluating an HMG-CoA reductase inhibitor for growth and bone abnormalities in children with Noonan syndrome has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome [Phase 3]
Phase 3 trial assessing long-term efficacy and safety of two doses of NN-220 (somatropin) in short stature due to Noonan syndrome has comple…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome [Phase 3]
Phase 3 trial assessing the effect of somatropin on linear growth and final height in individuals with Noonan syndrome.
-
CLINICAL_TRIALS trial_result · 2010-10-05Clinical Trial Update: Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome [Phase 3]
Phase 3 trial evaluating MAXOMAT for growth in young children with Noonan syndrome has completed. The sponsor is Sanofi.
-
CLINICAL_TRIALS trial_result · 2007-03-30Clinical Trial Update: Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome [Phase 2]
A Phase 2 trial evaluating a combination of recombinant human insulin-like growth factor-1 and recombinant human insulin-like growth factor …